Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

adidas Group: Impressive start to the year

BUY, Fair Value EUR122 vs. EUR108 (+7%)

Published last April Thursday 28, 2016

Capgemini: Q1 sales globally in line, FY16 guidance reiterated

BUY, Fair Value EUR90 (+15%)

Published last April Wednesday 27, 2016

Delhaize: Q1 2016 (first take): strong commercial momentum / clarification needed on FCF

BUY, Fair Value EUR104,5 vs. EUR105 (+14%)

Published last April Wednesday 27, 2016

STMicroelectronics: Q1 results below forecasts, but Q2 on track as the environment improves

NEUTRAL, Fair Value EUR6.3 (+24%)

Published last April Wednesday 27, 2016

Bayer: Mixed overall picture in Q1

NEUTRAL, Fair Value EUR110 (0%)

Published last April Wednesday 27, 2016

Ingenico Group: Strong Q1 sales. FY organic sales growth target upgraded and still cautious.

BUY, Fair Value EUR144 (+44%)

Published last April Wednesday 27, 2016
Bryan Garnier advises Tado° on $23m Equity Investment from Inven Capital

Bryan Garnier advises Tado° on $23m Equity Investment from Inven Capital

Published last April Tuesday 26, 2016

Bayer: Well ahead of its guidance after Q1 but no increase, poor cash-flow

Published last April Tuesday 26, 2016

Telecom services: Q1 2016 results: trend slowly improving

Telecom Services

Published last April Tuesday 26, 2016

Sword Group: Q1 16 results in line with our estimates, FY16 guidance fine-tuned from fx

BUY, Fair Value EUR26 (+9%)

Published last April Tuesday 26, 2016

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities